Rodger is a Venture Partner based in Switzerland supporting SR One on new company formation and early-stage investment. Rodger is a serial entrepreneur, long-time pharmaceutical and biotechnology senior executive. In 2013 he co-founded CRISPR Therapeutics, led the team that IPO’d the company in 2016 and led CRISPR as CEO until December 2017. Rod...
Roles at SR One Capital Management